Evidence map›Paper›PMID 30678308›Full record

ArticleMolecules (Basel, Switzerland)2019

Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS.

Mohammad H Semreen, Sameh S M Soliman, Balsam Q Saeed, Abdullah Alqarihi, Priya Uppuluri, Ashraf S Ibrahim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. The effects of tyrosol on yeasts: an overview of current knowledge.Applied microbiology and biotechnology · 2025
    Review
  4. Review
  5. Metabolic Patterns of Fluconazole Resistant and SusceptibleJournal of fungi (Basel, Switzerland) · 2024
    Article
  6. Multi-Omics Profiling ofMicroorganisms · 2023
    Article
  7. Article
  8. Review
  9. Sample Preparation in Microbial Metabolomics: Advances and Challenges.Advances in experimental medicine and biology · 2023
    Article
  10. Article
  11. Metabolic Plasticity ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  12. Phenolic Contents and Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mohammad H SemreenSharjah Institute for Medical Research and College of Pharmacy, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates. msemreen@sharjah.ac.ae.
Sameh S M SolimanSharjah Institute for Medical Research and College of Pharmacy, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates. ssoliman@sharjah.ac.ae.
Balsam Q SaeedDepartment of Clinical Sciences, College of Medicine, University of Sharjah, P.O. Box 27272, Sharjah, United Arab Emirates. bsaeed@sharjah.ac.ae.
Abdullah AlqarihiDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, 90509, USA. aalqarihi@labiomed.org.
Priya UppuluriDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, 90509, USA. puppuluri@labiomed.org.
Ashraf S IbrahimDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, 90509, USA. ibrahim@labiomed.org.
University of Sharjah · AEUniversity of California, Los Angeles · USThe Lundquist Institute · US

Funding

Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens SupplementR01AI141202 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2019 to 2023
$5.7M
Development of Immunotherapeutic Strategies to Overcome Neonatal CandidiasisR21HD097480 · NICHD · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI UPPULURI, PRIYA · 2019 to 2020
$446k
NIAID NIH HHS R01 AI141202NICHD NIH HHS R21 HD097480
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, Multiple, FungalMetabolomeMetabolomicsCandidaComputational BiologyFermentationGas Chromatography-Mass SpectrometryHyphaeCandida aurisGC-MShyphaemetabolic profilingmorphogenesisyeast

Identifiers

PMID30678308
PMCPMC6384714
OpenAlexW2914003150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.